Key facts
- The U.S. and Uzbekistan signed an MOU to boost investment.
- The MOU covers sectors like mining, energy, IT, agriculture, and AI.
- The U.S. strategy aims to secure critical minerals supply chains away from China.
- Officials met in Astana to discuss investment deals.
- Uzbekistan plans subsidies to boost pharmaceutical investment.
- Uzbekistan is considering policies to simplify regulatory approvals for pharma investment.
- Uzbekistan aims to attract investment from Indian pharmaceutical companies.
The United States and Uzbekistan have signed a Memorandum of Understanding (MOU) to significantly enhance bilateral investment, focusing on strategic sectors such as mining, energy, information technology, agriculture, and artificial intelligence. This pact is a component of a larger U.S. strategy to secure and diversify global supply chains for critical minerals, aiming to lessen dependence on China. Officials from both nations convened in Astana to deliberate on specific investment opportunities and finalize concrete deals.
In parallel, Uzbekistan is actively seeking to bolster its domestic pharmaceutical industry by attracting foreign investment. The Uzbek government is contemplating the implementation of new policies designed to streamline regulatory approval processes and introduce enhanced investment incentives. These measures are specifically targeted at encouraging pharmaceutical companies, particularly those based in India, to establish or expand their manufacturing operations within Uzbekistan. The goal is to foster local production and potentially reduce reliance on imported pharmaceuticals.